4 Coronavirus Penny Stocks Soaring on March 16

Coronavirus Penny Stocks

Coronavirus penny stocks are back in action.

The coronavirus pandemic has escalated at an alarming rate and has resulted in complete turmoil in the markets all across the world. The epidemic, as things stand, is one of the most damaging in modern history, and as of now, the troubles are going to continue worldwide. When it all started, it seemed like it was a localized issue in China, and the markets were not at risk, but over the past two weeks, it has become abundantly clear that it is a pandemic.

Markets in the United States have nosedived, and the carnage continued this morning. According to data compiled by John Hopkins University, the number of cases stands at 1,69,387 worldwide and 3,774 in the United States. The University has also revealed that the number of deaths now stands at 3,774 globally and at 69 in the United States. The resulting turmoil in the markets is not really a surprise.

However, even during this carnage, there are certain stocks that investors could consider tracking at this stage. Here is a quick look at four coronavirus penny stocks that investors could watch today.

Coronavirus Penny Stocks: OpGen Inc (NASDAQ:OPGN)

The very first coronavirus stock that has come into sharp focus today in the markets is that of OpGen Inc. This morning, the company announced an update with regards to Curetis GmbH, the company with which it is going to collaborate on a CE-IVD certified real-time PCR test kit for coronavirus.

>> 4 Biotech Penny Stocks That Are Up Over 100% So Far in 2020

The specific pathogen that the test kit is meant to decipher is 2019-nCov. It was announced today that Curetis has started offering this product, which is going to be made available through the European sales channels of the company. It is a massive development for OpGen Inc, and the market reacted with optimism.

The stock soared by as much as 120% on the back of the announcement, and it remains to be seen how it fares for the rest of the day. Investors could do well to keep an eye on the stock.

Coronavirus Penny Stocks: BioNTech (NASDAQ:BNTX)

Coronavirus Penny Stocks

The other coronavirus-related stock that has been flying in premarket trading this morning is that of BioNTech SE. It is normally a thinly traded stock, but this morning it jumped on the back of a major announcement. The company revealed that it is aiming to begin clinical testing for its product, BNT162. The product in question is an mRNA vaccine and is meant to be a candidate that can be used to tackle the coronavirus. The testing is expected to begin towards the end of April, but that is subject to regulatory approval.

The development proved to be a massive boost for BioNTech stock, as investors piled on to it this morning, and the stock soared by as much as 31%. The company is aiming to develop the product in collaboration with Fosun Pharma in China.

Coronavirus Penny Stocks: Beyond Air Inc (NASDAQ:XAIR)

XAIR stock has also soared today on the back of an important development. The company is involved in producing inhaled Nitric Oxide for patients with respiratory troubles. Today it announced that it has submitted an Investigational Device Exemption (IDE) application for its LungFitTM BRO system to the United States Food and Drug Administration.

>> 3 Healthcare Penny Stocks Up Over 200% (Thanks to Biden & COVID-19)

The hope is that the product will be able to help treat patients who are suffering from the coronavirus infection. This is a significant development since an IDE approval does not take very long; generally, the FDA provides it within a matter of 30 days.

This explains the significant interest in Beyond Air stock this morning, which recorded gains of 20% so far.

Coronavirus Penny Stocks: Allied Healthcare Products Inc (NASDAQ:AHPI)

Coronavirus Penny Stocks

Last but not least is Allied Healthcare stock, which has emerged as another strong gainer amidst coronavirus stocks this morning. However, what sets Allied stock apart is that it has gained 300% since the end of February.

The company is involved in manufacturing respiratory therapy equipment and home healthcare items, among other things. Considering the spread of the coronavirus epidemic, investors might be thinking that Allied could see a major spike in its business. Of course, this is only speculation.

AHPI stock continued to rally today and has soared by 19% so far.

What Next?

The coronavirus pandemic is expected to continue being a major influence on the stock market over the coming days. So, one needs to evaluate the proper risk-reward ratio before considering any Coronavirus penny stocks.

>> Read More Biotech News

Featured image: PixaBay

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.